No going back  :  Pharma companies’ route to a digitized go-to-market model   / [authors, Thomas Solbach ... et al.] 
.-- [S.l.]:  PwC,  2020 
.-- 13 p.:  gráf. ;  1 documento PDF 
<br/><br/><label><b>Notas:</b></label><br/><br/> En la cubierta: "As COVID-19 digitizes healthcare, we suggest five steps for pharma companies to transform their market engagement 
<br/><br/> Digital technologies and interactions are transforming healthcare at an accelerating pace. Until recently, most touchpoints between physicians and pharma companies depended on face-to-face interaction, which often required field forces to drive hundreds of time-consuming kilometers for meetings with doctors.  
<br/><br/><label><b>Materias:</b></label> Sanidad digital<br/>
<br/><br/><label><b>Términos de indización - No controlado:</b> </label>COVID-19  <br/>digitized  <br/>healthcare  <br/>technological advances   <br/>Transformación digital  <br/>
<br/><br/><label><b>Encabezamiento secundario--Nombre personal:</b> </label> Solbach, Thomas <br/>
<br/><br/><label><b>Encabezamiento secundario--Nombre de entidad:</b> </label> PricewaterhouseCoopers‏<br/>